Curis | CRIS - Attività Correnti





Attività Correnti Cambiamento Data
Alaunos Therapeutics USD 666K 304K 2026-06
Amgen USD 34.36B 598M 2026-09
AstraZeneca USD 31.45B 3.48B 2026-09
Bayer EUR 39.6B 5.96B 2026-09
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
CSL USD 11.85B 1000K 2025-12
Curis USD 16.61M 9.7M 2026-03
Eli Lilly USD 65.26B 591M 2026-09
Exelixis USD 1.32B 70.8M 2026-09
Gilead Sciences USD 16.55B 4.02B 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
Incyte USD 5.52B 505.2M 2026-09
Merck USD 38.94B 2.26B 2026-09
Novartis USD 28.75B 1.4B 2026-09
Pfizer USD 45.01B 3.65B 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 33.21B 1.68B 2026-09
Takeda JPY 3T 153.11B 2026-09
TG Therapeutics USD 1.15B 58.72M 2026-06
Verastem USD 202.9M 20.51M 2026-03